View : 22 Download: 0

Interference with TGF-β signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria

Title
Interference with TGF-β signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria
Authors
Wang A.Ziyadeh F.N.Eun Y.L.Pyagay P.E.Sun H.S.Sheardown S.A.Laping N.J.Chen S.
Ewha Authors
성순희
SCOPUS Author ID
성순희scopus
Issue Date
2007
Journal Title
American Journal of Physiology - Renal Physiology
ISSN
0363-6127JCR Link
Citation
vol. 293, no. 5, pp. F1657 - F1665
Indexed
SCOPUS WOS scopus
Abstract
Transforming growth factor (TGF)-β plays a critical role in diabetic nephropathy. To isolate the contribution of one of the signaling pathways of TGF-β, the Smad3 gene in the mouse was knocked out at exons 2 and 3, and the effect was studied in streptozotocin (STZ)-induced diabetes over a period of 6 wk. TGF-β activity was increased in the diabetic mice but was not able to signal via Smad3 in the knockout (KO) mice. As expected in the wild type, the kidneys of the STZ-diabetic mice showed both structural and functional defects that are characteristic of diabetic renal involvement. In the Smad3-KO mice, however, the defects that were improved were renal hypertrophy, mesangial matrix expansion, fibronectin overproduction, glomerular basement membrane thickening, plasma creatinine, and the blood urea nitrogen. The parameters not significantly altered by the Smad3-KO were albuminuria, reduction in podocyte slit pore density, and the increase in vascular endothelial growth factor abundance and activity. It seems that the absence of Smad3 modifies the natural course of murine diabetic nephropathy, providing renal functional protection and preventing structural lesions relating to kidney hypertrophy and matrix accumulation, even though albuminuria and changes in podocyte morphology persist. In conclusion, the effects of the Smad3-KO mirror the effects of anti-TGF-β therapy in diabetes, suggesting that the chief component of TGF-β signaling that is relevant to kidney disease is the Smad3 pathway. Copyright © 2007 the American Physiological Society.
DOI
10.1152/ajprenal.00274.2007
Appears in Collections:
의학전문대학원 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE